Market Overview:
Smallpox is a highly contagious and deadly disease caused by the variola virus. The smallpox vaccine is the only effective means of prevention. The global smallpox treatment market was valued at US$ XX Mn in 2017 and is expected to grow at a CAGR of XX% over the forecast period 2018-2030, to reach US$XX Mn by 2030. The global smallpox treatment market can be segmented on the basis of type into drugs and vaccines. On the basis of application, it can be segmented into hospital, clinic, and other applications such as research laboratories etc. Geographically, it can be segmented into North America, Latin America, Europe Asia Pacific and Middle East & Africa (MEA). North America dominates the global smallpox treatment market followed by Europe due to better healthcare infrastructure in these regions.
Product Definition:
Smallpox is a highly contagious and deadly disease caused by the variola virus. It was once a common global illness, but has been largely eradicated due to vaccination efforts. There is no specific smallpox treatment available, but early diagnosis and supportive care can improve the chances of survival. Smallpox is considered a potential bioterrorism agent and thus proper medical preparedness for its use is important.
Drugs:
The global drugs, it's usage and growth factor in smallpox treatment market size was valued at USD 2.8 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of diseases such as AIDS, cancer, tuberculosis, leprosy &cancroidsis anticipated to drive the demand for drugs used for their treatment during the forecast period.
Vaccines:
Vaccines are biological agents, which are used to stimulate the body's immune system to act against an infectious disease. There are two types of vaccines-invasive and non-invasive. The most common type of vaccine is the oral or injectable one, which is given to prevent diseases like polio, measles, mumps and rubella among others.
Application Insights:
The other application segment held the largest share of over 60.0% in 2017. The demand for smallpox treatment is expected to be high among individuals affected with naturally-acquired immunity as well as those who are not immune and have contracted smallpox. In addition, the hospital application segment is anticipated to witness lucrative growth during the forecast period owing to its usage in hospitals and clinical research settings for individuals who are unresponsive or cannot be treated at home due to their severe condition caused by smallpox infection.
Clinical trials pertaining to SFTD use have been conducted in Africa, Asia Pacific, Europe and North America; however, these trials were either observational studies or used placebos without any active Comparator arm (injections).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of smallpox patients, high government spending on R&D, and availability of a well-established healthcare infrastructure. Moreover, increasing demand for biologics in this region is expected to drive growth over the forecast period.
Asia Pacific is estimated to be the fastest-growing regional market during the forecast period due to factors such as growing population and awareness regarding smallpox disease control measures. The outbreak of COVID 19 has resulted in an increase in demand for smallpox treatment products such as drugs and vaccines among countries from Asia Pacific region. For instance, Australia’s federal police force have requested emergency supplies including two vials each of vaccine against Smallpox (VSU) manufactured by CSL Limited (CSL).
Growth Factors:
- Increasing incidence of smallpox
- Emergence of new and more effective therapies
- Growing demand for smallpox vaccines
- Rising awareness about smallpox prevention and treatment options
- Technological advancements in the field of smallpox treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Smallpox Treatment Market Research Report
By Type
Drugs, Vaccines
By Application
Hospital, Clinic, Other
By Companies
Bavarian Nordic AS, Emergent BioSolutions Inc., Pfizer Inc., SIGA Technologies Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Smallpox Treatment Market Report Segments:
The global Smallpox Treatment market is segmented on the basis of:
Types
Drugs, Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bavarian Nordic AS
- Emergent BioSolutions Inc.
- Pfizer Inc.
- SIGA Technologies Inc.
Highlights of The Smallpox Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drugs
- Vaccines
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Smallpox Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Smallpox is a highly contagious virus that can cause severe skin lesions, fever, and pneumonia. Treatment typically includes antibiotics to fight the infection and pain relief for the symptoms. In some cases, surgery may be necessary to remove the lesions.
Some of the key players operating in the smallpox treatment market are Bavarian Nordic AS, Emergent BioSolutions Inc., Pfizer Inc., SIGA Technologies Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Smallpox Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Smallpox Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Smallpox Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Smallpox Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Smallpox Treatment Market Size & Forecast, 2018-2028
4.5.1 Smallpox Treatment Market Size and Y-o-Y Growth
4.5.2 Smallpox Treatment Market Absolute $ Opportunity
Chapter 5 Global Smallpox Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Smallpox Treatment Market Size Forecast by Type
5.2.1 Drugs
5.2.2 Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Smallpox Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Smallpox Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Smallpox Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Smallpox Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Smallpox Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Smallpox Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Smallpox Treatment Market Size Forecast by Type
9.6.1 Drugs
9.6.2 Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Smallpox Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Smallpox Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Smallpox Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Smallpox Treatment Market Size Forecast by Type
10.6.1 Drugs
10.6.2 Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Smallpox Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Smallpox Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Smallpox Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Smallpox Treatment Market Size Forecast by Type
11.6.1 Drugs
11.6.2 Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Smallpox Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Smallpox Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Smallpox Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Smallpox Treatment Market Size Forecast by Type
12.6.1 Drugs
12.6.2 Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Smallpox Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Smallpox Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Smallpox Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Smallpox Treatment Market Size Forecast by Type
13.6.1 Drugs
13.6.2 Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Smallpox Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Smallpox Treatment Market: Competitive Dashboard
14.2 Global Smallpox Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bavarian Nordic AS
14.3.2 Emergent BioSolutions Inc.
14.3.3 Pfizer Inc.
14.3.4 SIGA Technologies Inc.
